BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32655824)

  • 1. Prognostic value of combined preoperative gamma-glutamyl transpeptidase to platelet ratio and fibrinogen in patients with HBV-related hepatocellular carcinoma after hepatectomy.
    Dai T; Deng M; Ye L; Liu R; Lin G; Chen X; Li H; Liu W; Yang Y; Chen G; Wang G
    Am J Transl Res; 2020; 12(6):2984-2997. PubMed ID: 32655824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative γ-glutamyl transpeptidase to platelet ratio (GPR) is an independent prognostic factor for HBV-related hepatocellular carcinoma after curative hepatic resection.
    Wang WL; Zheng XL; Zhang ZY; Zhou Y; Hao J; Tang G; Li O; Xiang JX; Wu Z; Wang B
    Medicine (Baltimore); 2016 Jul; 95(27):e4087. PubMed ID: 27399101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection.
    Wu W; Wang Q; Han D; Li J; Nie Y; Guo D; Yang L; Tao K; Zhang X; Dou K
    Cancer Cell Int; 2021 Sep; 21(1):500. PubMed ID: 34535132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of γ-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy.
    Liu KJ; Lv YX; Niu YM; Bu Y
    Medicine (Baltimore); 2020 Nov; 99(48):e23339. PubMed ID: 33235099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation.
    Fu SJ; Ji F; Han M; Chen MG; Wang XP; Ju WQ; Zhao Q; Wu LW; Ren QQ; Guo ZY; Wang DP; Zhu XF; Ma Y; He XS
    Oncotarget; 2017 Jan; 8(3):4301-4312. PubMed ID: 27935864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of fibrinogen to prealbumin ratio and gamma-glutamyl transpeptidase to platelet ratio in the progression of AFP-negative hepatocellular carcinoma.
    Huang L; Mo Z; Hu Z; Zhang L; Qin S; Qin X; Li S
    Cancer Cell Int; 2020; 20():77. PubMed ID: 32190001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new model based on gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts prognostic outcome after curative resection of solitary hepatocellular carcinoma.
    Yang D; Wu H; Nong W; Zheng M; Li A; Wang Y; Li M; Chen Q; Yuan S; Yu J; Liao W
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101509. PubMed ID: 33744828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of Nomograms Based on Gamma-Glutamyl Transpeptidase to Platelet Ratio for Hepatocellular Carcinoma Patients Reveal Novel Prognostic Value and the Ratio Is Negatively Correlated With P38MAPK Expression.
    Luo D; Li H; Hu J; Zhang M; Zhang S; Wu L; Han B
    Front Oncol; 2020; 10():548744. PubMed ID: 33344225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-glutamyl transpeptidase to platelet ratio predicts short-term outcomes in hepatocellular carcinoma patients undergoing minor liver resection.
    Ke MY; Zhang M; Su Q; Wei S; Zhang J; Wang Y; Wu R; Lv Y
    J Surg Res; 2018 Nov; 231():403-410. PubMed ID: 30278960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a prognostic model based on the albumin-to-fibrinogen ratio (AFR) and gamma-glutamyl transpeptidase-to-platelet ratio (GPR) in hepatocellular carcinoma patients.
    Zhang J; Wang T; Xu L; Wang P; Zhang M; Xu M
    Clin Chim Acta; 2020 Dec; 511():107-116. PubMed ID: 33035501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-Glutamyl Transpeptidase to Platelet Ratio Is a Novel and Independent Prognostic Marker for Resectable Lung Cancer: A Propensity Score Matching Study.
    Zhao L; Li S; Ju J; Zhou H; Wang H; Che G
    Ann Thorac Cardiovasc Surg; 2021 Jun; 27(3):151-163. PubMed ID: 33536389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple models based on gamma-glutamyl transpeptidase and platelets for predicting survival in hepatitis B-associated hepatocellular carcinoma.
    Pang Q; Bi JB; Wang ZX; Xu XS; Qu K; Miao RC; Chen W; Zhou YY; Liu C
    Onco Targets Ther; 2016; 9():2099-109. PubMed ID: 27110127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer.
    Park YE; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Han S; Jeon MY; Heo JY; Song K; Kim SU
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1221-1229. PubMed ID: 27859587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Value of Platelet-Related Measures in Patients with Hepatocellular Carcinoma.
    Fan Z; Wu M; Tang Z; He A; Liu F; Liang W; Wang Z; Yang D
    Technol Cancer Res Treat; 2022; 21():15330338211064414. PubMed ID: 35225081
    [No Abstract]   [Full Text] [Related]  

  • 16. The value of neutrophil to lymphocyte ratio and gamma-glutamyl transpeptidase to platelet ratio in patients with hepatocellular carcinoma.
    Hu Z; Chen H; Chen S; Huang Z; Qin S; Zhong J; Qin X; Li S
    Medicine (Baltimore); 2019 Mar; 98(9):e14749. PubMed ID: 30817633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q; Li W; Huang Y; Chen L
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative elevated plasma fibrinogen level predicts tumor recurrence and poor prognosis in patients with hepatocellular carcinoma.
    Dai T; Peng L; Lin G; Li Y; Yao J; Deng Y; Li H; Wang G; Liu W; Yang Y; Chen G; Wang G
    J Gastrointest Oncol; 2019 Dec; 10(6):1049-1063. PubMed ID: 31949922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of GPR, APPRI and FIB-4 in the early diagnosis of hepatocellular carcinoma: a prospective cohort study.
    Zhang L; Li S; Zhang D; Yin C; Wang Z; Chen R; Cheng N; Bai Y
    Jpn J Clin Oncol; 2024 Feb; 54(2):129-136. PubMed ID: 37869774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum gamma-glutamyl transpeptidase-to-platelet ratio (GPR) can predict the prognosis of hepatocellular carcinoma: a meta-analysis and systematic review.
    Ma C; Wang N; Ma H; Song K; Yu R; Chen H
    Transl Cancer Res; 2022 Apr; 11(4):745-753. PubMed ID: 35571666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.